These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 1084968)
1. Beneficial effects of serotonin precursors in postanoxic action myoclonus. De Léan J; Richardson JC; Hornykiewicz O Neurology; 1976 Sep; 26(9):863-8. PubMed ID: 1084968 [TBL] [Abstract][Full Text] [Related]
2. Therapy of intention myoclonus with L-5-hydroxytryptophan and a peripheral decarboxylase inhibitor, MK 486. Van Woert MH; Sethy VH Neurology; 1975 Feb; 25(2):135-40. PubMed ID: 1078720 [TBL] [Abstract][Full Text] [Related]
3. Biochemistry and therapeutics of posthypoxic myoclonus. Van Woert MH; Rosenbaum D; Chung EY Adv Neurol; 1986; 43():171-81. PubMed ID: 2418644 [No Abstract] [Full Text] [Related]
4. Pathological findings in a case of hypoxic myoclonus treated with 5-hydroxytryptophan and a decarboxylase inhibitor. De Léan J; Richardson JC; Rewcastle NB Adv Neurol; 1986; 43():215-23. PubMed ID: 2418647 [TBL] [Abstract][Full Text] [Related]
5. Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepam. Chadwick D; Hallett M; Harris R; Jenner P; Reynolds EH; Marsden CD Brain; 1977 Sep; 100(3):455-87. PubMed ID: 412560 [TBL] [Abstract][Full Text] [Related]
6. Clinical, biochemical, and pharmacological observation in a patient with postasphyxic myoclonus: association to serotonin hyperactivity. Giménez-Roldán S; Mateo D; Muradas V; De Yebenes JG Clin Neuropharmacol; 1988 Apr; 11(2):151-60. PubMed ID: 2454156 [TBL] [Abstract][Full Text] [Related]
8. Long-term therapy of myoclonus and other neurologic disorders with L-5-hydroxytryptophan and carbidopa. Van Woert MH; Rosenbaum D; Howieson J; Bowers MB N Engl J Med; 1977 Jan; 296(2):70-5. PubMed ID: 401457 [TBL] [Abstract][Full Text] [Related]
9. Treatment of posthypoxic action myoclonus: implications for the pathophysiology of the disorder. Chadwick D; Hallett M; Jenner P; Marsden CD Adv Neurol; 1986; 43():183-90. PubMed ID: 2418645 [No Abstract] [Full Text] [Related]
10. Postanoxic myoclonus. Treatment of a case with 5-hydroxytryptophane and a decarboxylase inhibitor. Beretta E; Regli F; de Crousaz G; Steck AJ J Neurol; 1981; 225(1):57-62. PubMed ID: 6164757 [TBL] [Abstract][Full Text] [Related]
12. Post-hypoxic intention myoclonus treated with 5-hydroxy-tryptophan and an extracerebral decarboxylase inhibitor. Magnussen I; Dupont E; Engbaek F; de Fine Olivarius B Acta Neurol Scand; 1978 Apr; 57(4):289-94. PubMed ID: 307327 [TBL] [Abstract][Full Text] [Related]
13. Fluoxetine in the treatment of intention myoclonus. Van Woert MH; Magnussen I; Rosenbaum D; Chung E Clin Neuropharmacol; 1983 Mar; 6(1):49-54. PubMed ID: 6189599 [TBL] [Abstract][Full Text] [Related]
14. Clinical and metabolic observations on the treatment of myoclonus with L-5-HTP and carbidopa. Thal L; Sharpless N; Wolfson L; Engel J; Katzman R Trans Am Neurol Assoc; 1976; 101():48-52. PubMed ID: 1088459 [No Abstract] [Full Text] [Related]
15. Manipulation of brain serotonin in the treatment of myoclonus. Chadwick D; Jenner P; Harris R; Reynolds EH; Marsden CD Lancet; 1975 Sep; 2(7932):434-5. PubMed ID: 51240 [TBL] [Abstract][Full Text] [Related]
16. L-5-hydroxytryptophan in treatment of several different syndromes in which myoclonus is prominent. Growdon JH; Young RR; Shahani BT Neurology; 1976 Dec; 26(12):1135-40. PubMed ID: 1086988 [TBL] [Abstract][Full Text] [Related]
17. [Utilization of levo-5-hydroxytryptophan in post-anoxic myoclonus]. Rascol A; Guiraud-Chaumeil B; Laboucarie J; Montastruc JL; El-Hage W Therapie; 1978; 33(5):623-8. PubMed ID: 311085 [No Abstract] [Full Text] [Related]
18. Improvement of action myoclonus by an administration of 5-hydroxytryptophan and carbidopa in a child with muscular subsarcolemmal hyperactivity. Nakano K; Hayakawa T; Shishikura K; Ohsawa M; Suzuki H; Fukuyama Y Brain Dev; 1990; 12(5):516-20. PubMed ID: 2288384 [TBL] [Abstract][Full Text] [Related]
19. Treatment of myoclonus with L-5-hydroxytryptophan and carbidopa: clinical, electrophysiological, and biochemical observations. Thal LJ; Sharpless NS; Wolfson L; Katzman R Ann Neurol; 1980 Jun; 7(6):570-6. PubMed ID: 6969054 [TBL] [Abstract][Full Text] [Related]